Imexpharm Corp
VN:IMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
M
|
Mandom Corp
F:MD9
|
JP |
|
W
|
Weng Fine Art AG
F:WFA
|
DE |
|
Z
|
Ziff Davis Inc
XMUN:JXC1
|
US |
|
R
|
Rogers Corp
F:RG6
|
US |
|
Contango ORE Inc
TSX:CTGO
|
US |
|
Fortune Minerals Ltd
TSX:FT
|
CA |
Wall St Price Targets
IMP Price Targets Summary
Imexpharm Corp
According to Wall Street analysts, the average 1-year price target for IMP is 56 440 VND with a low forecast of 54 035 VND and a high forecast of 59 325 VND.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMP's stock price target?
Price Target
56 440
VND
According to Wall Street analysts, the average 1-year price target for IMP is 56 440 VND with a low forecast of 54 035 VND and a high forecast of 59 325 VND.
What is the Revenue forecast for Imexpharm Corp?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for Imexpharm Corp?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Imexpharm Corp?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 23%.
What is the Pre-Tax Income forecast for Imexpharm Corp?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Imexpharm Corp?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 28%.
